Deciphera Pharmaceuticals Announces FDA Orphan Drug Designation for DCC-2618 for the Treatment of Glioblastoma Multiforme and Anaplastic Astrocytoma Waltham, MA – September 5, 2017 – Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on...
Iterum Gains Important Support for Development of Novel Oral Antibiotic, Sulopenem • CARB-X selects Iterum’s sulopenem to receive $1.5 million investment • Funding recognizes urgent need for new therapies against resistant bacteria DUBLIN, IRELAND – July 25th, 2017 –...
NJEA: Union-led Effort Nets $1.6 Billion in Prescription Savings The State of New Jersey School Employees Health Benefits Program (SEHBP) and State Health Benefits Program (SHBP) announced the results of a Pharmacy Benefits Manager bidding process using Truveris...
Oxford Immunotec Announces National Reimbursement For The T-SPOT®.TB Test In France OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on...
Kyruus Enhances Its Clinical Leadership with New Chief Medical Officer, Erin Jospe, M.D. Boston, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that Erin Jospe, M.D., has joined its leadership team as the...
Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation OXFORD, United Kingdom and MARLBOROUGH, Mass., June 15, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company...
Recent Comments